Exam 2: GI and Liver Flashcards

(52 cards)

1
Q

Pre-op restriction on clear liquids:

A

2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pre-op restriction on breast milk:

A

4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pre-op restriction on light meals, milk, or formula:

A

6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pre-op restriction on heavy meals:

A

8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pre-op restriction on sips of water for meds:

A

1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Patients who are aspiration risks (8):

A
Age extremes ( 70)
Ascites
Hiatal hernia/GERD/esophageal surgery
Mechanical obstruction
Metabolic disorders
Neurologic diseases
Pregnancy
Prematurity

AAHMMNPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Four greatest risks for aspiration:

A

Pregnant
Morbidly obese
Hiatal hernia
Preoperative anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aspiration prophylaxis:

A

H2 receptor antagonists
Sodium citrate/Bicitra
Metoclopramide/Reglan
PPI (i.e. omeprazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Use of H2 blockers pre-op:

A

Best given night before & 45-60 minutes pre-op
Famotidine: best result
Also cimetidine, ranitidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Indications, MoA, and contraindications for pre-op metoclopramide:

A

Dopamine antagonism ↑ pressure on LES which speeds gastric emptying
Prevents/alleviates N/V
CONTRAINDICATED in obstruction!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MoA, dose, and timing of sodium citrate pre-op:

A

30mL, 15 minutes before surgery to raise gastric pH (also raises volume, though)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mendelson Syndrome characterized by:

A

Aspiration of > 25ml of gastric material at

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Manifestations of Mendelson Syndrome:

A
Respiratory distress
Bronchospasm
Cyanosis
Tachycardia
Dyspnea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tx for Barrett’s esophagus:

A

H2 blockers and PPIs

Nissen fundoplication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

S/s of hiatal hernia:

A

Retrosternal discomfort
Burning after meals
+/- reflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tx of hiatal hernia:

A

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk factors for PUD:

A
H. pylori
Age 45-60
Chronic NSAIDs
ETOH
Steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

S/s of PUD:

A
Epigastric pain
Vomiting
Hematemesis/melena
Abdominal tender/rigid
Perforation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tx of PUD:

A

H2 blockers and PPIs
Abx
Antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tx of PUD:

A

H2 blockers and PPIs
Abx
Antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

S/s of gastric ulcers:

A

Pain
Anorexia
Weight loss
Metabolic derangements

22
Q

Important pre-op considerations for malabsorption syndromes:

A

Fluids and electrolytes

Vitamin K levels!

23
Q

Important pre-op considerations for malabsorption syndromes:

A

Fluids and electrolytes

Vitamin K levels!

24
Q

S/s of malabsorptions syndromes:

A
Weight loss
Steatorrhea
Diarrhea
Anemia
Fatigue
Vitamin deficiency
Dyscrasias
Edema/ascites
25
Lab abnormalities in Crohn's disease:
Deficiencies in magnesium, B12, phosphorus, folic acid, zinc, iron, postassium, albumin Anemia
26
Carcinoid syndrome is:
Mild, non-metastatic cancer originating in the GI tract
27
Substances secreted by carcinoid cancers:
Bradykinin Histamine Serotonin Dopamine
28
Skin signs of GI problems:
``` Jaundice Small veins Cracked lips Turgor (mostly fluid-related) ```
29
Useful GI labs:
Hgb/hct (fluid status) Electrolytes BUN/Cr Serum albumin
30
Serum albumin range:
Should be > 4
31
Liver's blood reservoir %:
10-15%
32
Risk factors for chronic liver disease:
``` Blood transfusions Jaundice Drugs/ETOH Meds/fish oil Travel hx Occupational hx ```
33
S/s of liver disease:
``` Bruising Anorexia Weight changes N/V Pain Itching GI bleeding ```
34
Two grading scales for liver dysfunction:
MELD | Child-Turcotte-Pugh
35
Factors in the Child-Turcotte-Pugh scoring system:
``` ABE APP: Ascites Bilirubin Encephalopathy Albumin PT/INR Primary biliary cirrhosis ```
36
Lab tests for liver function:
``` AAAA B CC NP: Ammonia AST/ALT Alk phos/GGT Albumin Bilirubin CBC Coags 5' Nucleotidase Prothrombin ```
37
Physical assessment for liver function:
``` Look for: Jaundice Ascites Dependent edema Asterixis ```
38
Anesthetic considerations for liver disease:
Often have enzyme induction and need ↑ sedatives Hyperdynamic circulatory state ↑ levels of endogenous vasodilators like VIP
39
Liver disease effects on respiratory status:
Ascites impairs diaphragm movement and ↓ FRC
40
Factors dependent on Vitamin K:
II, VII, IX, X | 2, 7, 9, 10
41
Absorption of Vitamin K depends on:
Bile salt excretion into the GI tract
42
Treatment of Hep B/C:
Interferon, ribavirin
43
Treatment of AI hepatitis:
Corticosteroids, AZT
44
Anesthetic considerations for hepatitis:
Aspiration precautions! | Look for s/s of encephalopathy, bleeding, ascites, etc.
45
Hours after ETOH withdrawal that tremors may be seen:
6-8 hours
46
Hours after ETOH withdrawal that seizures may be seen:
24 hours
47
Hours after ETOH withdrawal that DTs may be seen:
72 hours (but preceded by tremors, hallucinations, seizures)
48
Anesthetic considerations for cirrhosis:
Hyperdynamic circulation ↑ CO ↓ PVR
49
Clotting factors reduced in liver failure:
II, V, VII, IX, X | 2, 5, 7, 9, 10
50
Factors dependent on Vitamin K:
II, VII, IX, X (2, 7, 9, 10) | Protein C, Protein S
51
Clotting factors reduced in liver failure:
II, V, VII, IX, X (2, 5, 7, 9, 10)
52
Mechanism of platelet dysfunction in liver failure:
Thrombopoietin is produced by the liver and signals for platelet production in the bone marrow